Ovid Therapeutics Inc (OVID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 1,445 | 0 | 0 | 0 | 208,383 |
| Gross Profit | 1,445 | N/A | N/A | N/A | 208,383 |
| Operating Expenses | 17,713 | 26,354 | 11,682 | 14,313 | 31,826 |
| Operating Income | -16,267 | -26,354 | -11,682 | -14,313 | 176,557 |
| Other Income | 209 | 4 | 3 | -3 | -50 |
| Pre-tax Income | -16,058 | -26,350 | -11,679 | -14,315 | 176,508 |
| Income Tax | 50 | -350 | -295 | 1,473 | 500 |
| Net Income Continuous | -16,108 | -26,000 | -11,384 | -15,788 | 176,007 |
| Net Income | $-16,108 | $-26,000 | $-11,384 | $-15,788 | $176,007 |
| EPS Basic Total Ops | -0.23 | -0.37 | -0.17 | -0.23 | 2.55 |
| EPS Basic Continuous Ops | -0.23 | -0.44 | -0.17 | -0.23 | 2.66 |
| EPS Diluted Total Ops | -0.23 | -0.37 | -0.17 | -0.23 | 2.53 |
| EPS Diluted Continuous Ops | -0.23 | -0.44 | -0.17 | -0.23 | 2.64 |
| EBITDA(a) | $-16,193 | $-26,297 | $-11,630 | $-14,260 | $176,632 |